Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Spinal muscular atrophy (SMA) is 1 of the leading causes of infant mortality. SMA is mostly caused by low levels of Survival Motor Neuron (SMN) protein due to deletion of or mutation in the gene. Its nearly identical copy, , fails to compensate for the loss of due to predominant skipping of exon 7. Correction of exon 7 splicing by an antisense oligonucleotide (ASO), nusinersen (Spinraza™), that targets the intronic splicing silencer N1 (ISS-N1) became the first approved therapy for SMA. Restoration of SMN levels using gene therapy was the next. Very recently, an orally deliverable small molecule, risdiplam (Evrysdi™), became the third approved therapy for SMA. Here we discuss how these therapies are positioned to meet the needs of the broad phenotypic spectrum of SMA patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691903PMC
http://dx.doi.org/10.1177/2633105520973985DOI Listing

Publication Analysis

Top Keywords

orally deliverable
8
deliverable small
8
small molecule
8
spinal muscular
8
muscular atrophy
8
approved therapy
8
therapy sma
8
sma
5
molecule treatment
4
treatment spinal
4

Similar Publications

Orally Deliverable Engineered Porphyrin Nanohybrids Activate the cGAS-STING Axis and Enable Fusobacterium-Specific Targeting for Robust Immune Remodeling and Colorectal Cancer Regression.

ACS Appl Mater Interfaces

September 2025

Colorectal and Anal Disease Unit, Department of Gastrointestinal Surgery, Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Nanning, Guangxi Zhuang Autonomous Region 530021, P. R. China.

The susceptibility of colorectal cancer (CRC) cells to () infection pose significant challenges to CRC treatment and prevention. This study addresses these challenges by mobilizing cGAS/STING axis activation and -specific targeting, thereby achieving a multimodal treatment strategy for reversing the immunosuppressive microenvironment (ITM) and achieving targeted anti- therapy. Specifically, a hybrid nanoplatform CuPpIX@HM was engineered using and tumor cell membranes encapsulating ultrasound (US) stimulation-responsive copper protoporphyrin IX (CuPpIX).

View Article and Find Full Text PDF

The combined application of cis-cyclo(L-Phe-L-Pro) with antimicrobial proline-based 2,5-diketopiperazines significantly enhances anti-breast cancer activity by selectively targeting cancer stem cells.

Chem Biol Interact

August 2025

Laboratory Microbial Physiology and Biotechnology, Program of Biopharmaceutical Science and Department of Food and Nutrition, College of Bio-Convergence, and Functional Biomaterials Development Research Institute, Eulji University, Seongnam, 13135, Republic of Korea. Electronic address: genie6@eulji

Proline-based cyclic dipeptides (CDPs) from lactic acid bacteria are stereochemically diverse molecules, possessing oral bioavailability and significant pharmacological potential. Herein, we developed a robust two-step ion-exchange purification platform to comprehensively isolate 16 structurally defined CDPs from 82-h culture filtrates (CFs) of Lactobacillus plantarum LBP-K10. Utilizing cation (Amberlite IRA-120) and anion (Amberlite IRA-67) exchange chromatography, we generated the K10-CCDP-IV fraction from 82-h acetate membrane-filtered CFs, followed by CHCl extraction to obtain K10-CCDP-IV-MC.

View Article and Find Full Text PDF

Mammalian milk, a multifaceted developmental biofluid, has attracted new attention due to its diverse constituents and their implications for health and disease. Among these constituents, extracellular vesicles (EVs) have emerged as focal points of investigation. EVs, including exosomes and small EVs, have demonstrated biological activity in preclinical studies-including reports of enhancement of cognition and neural complexity, promotion of gastrointestinal development, barrier function and microbiome richness, the bolstering of immune response, and facilitation of musculoskeletal maturation in neonates.

View Article and Find Full Text PDF

Potential benefits of orally deliverable silymarin-loaded spirulina platensis in mitigating alcoholic liver disease.

Food Res Int

July 2025

State Key Laboratory of Marine Food Processing and Safety Control, Dalian Polytechnic University, Dalian 116034, Liaoning, China; Academy of Food Interdisciplinary Science, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, Liaoning, China; National Engineering Rese

Alcoholic liver disease (ALD), caused by excessive alcohol abuse, encompasses a battery of liver conditions including fatty liver to more severe conditions such as alcoholic hepatitis and cirrhosis. Silymarin derived from the dried fruits of Silybum marianum can shield the liver cells from alcohol damage and prevent toxins from penetrating and damaging the liver. Overcoming the challenges of silymarin's poor solubility, low bioavailability, and limited absorption is crucial to fully realize its health benefits.

View Article and Find Full Text PDF

Probiotics emerges as a promising option for ulcerative colitis (UC) treatment, but its application remains challenging due to insufficient colon-targeted delivery efficiency and survival against the inflammation-associated intestinal oxidative stress. To address these issues, here we report a supramolecular liposome-microgel complex (SLMC) incorporated with Bacillus subtilis spores (BSSs) and dexamethasone (DEX) for orally-deliverable probiotic UC therapy. Specifically, BSSs and cholesterols were conjugated with gelatin via diselenide ligation to prepare microgels, followed by supramolecular complexation with UC-targeted DEX-loaded liposome via microfluidic engineering.

View Article and Find Full Text PDF